TARPLIN, DOWNS & YOUNG, LLC

Lobbying for CRINETICS PHARMACEUTICALS · Pharmaceutical and therapeutic company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Health Issues

innovation, prescription drug pricing

Medicare/Medicaid

Medicare policy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.